Skip to content

Clinical trials

Active, not recruiting Carcinoma, Hepatocellular trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Active, not recruiting Country / region: South Korea Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20184
20192
20211
20226
20236

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Seoul National University Hospital4
Asan Medical Center3
AbbVie2
Bristol-Myers Squibb1
Eisai Inc.1
Exelixis1
Hoffmann-La Roche1
Jonggi Choi1
MedImmune LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular21
Liver Neoplasms5
Neoplasms4
Biliary Tract Neoplasms2
Colorectal Neoplasms2
Carcinoma1
Endometrial Neoplasms1
Liver Cirrhosis1
Neoplasm Metastasis1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.